Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Surgical acquires vascular repair technology:

This article was originally published in Clinica

Executive Summary

US Surgical and EndoTex Interventional Systems have agreed to collaborate on the development of vascular repair technologies for aortic aneurysms and AV fistulas. The companies plan to begin clinical trials of EndoTex' stent graft for abdominal aortic aneurysm repair later this year. The agreement gives US Surgical the right to acquire the stent grafts and delivery systems, which can be used for iliac, femoral and thoracic aneurysm repair. Around 300,000 patients suffer an aneurysm every year in the US but only a small percentage of cases can be treated surgically.

You may also be interested in...



ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.

Start-Up Snapshot: Sweetch, Automated AI Wellness Management

At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.

Topics

UsernamePublicRestriction

Register

MT083958

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel